Healthy volunteers needed to test safety of experimental drug ICP-538
NCT ID NCT07535099
First seen Apr 24, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This early-stage study tests whether the experimental drug ICP-538 is safe and tolerable in healthy adults. About 104 participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. This study does not aim to treat any disease, but gathers important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SERVICES RESEARCH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gobroad Hospital
RECRUITINGBeijing, Beijing Municipality, 102200, China
Contact
Conditions
Explore the condition pages connected to this study.